Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5540434 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5539947 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5541357 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5538412 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5536162 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5538030 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5531409 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5529631 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5533799 | 1.00 | BCHE (0.65) | BCHEACHE | |
| SCHEMBL5536963 | 1.00 | BCHE (0.65) | BCHEACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9580749-B2 | Dyes and labeled molecules | BIOTIUM, INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-9580749-B2 | Dyes and labeled molecules | BIOTIUM, INC. (US) | 2017-02-28 | — | — | US | disclosed |
| US-9102835-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2015-08-11 | — | — | US | disclosed |
| US-8877437-B1 | Methods of using dyes in association with nucleic acid staining or detection | BIOTIUM, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-8753814-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-8753814-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-20140106349-A1 | Dyes and Labeled Molecules | ALLELOGIC BIOSCIENCES CORPORATION (US) | 2014-04-17 | — | — | US | disclosed |
| US-20140106349-A1 | Dyes and Labeled Molecules | ALLELOGIC BIOSCIENCES CORPORATION (US) | 2014-04-17 | — | — | US | disclosed |
| US-20140073058-A1 | Methods of Using Dyes in Association with Nucleic Acid Staining or Detection and Associated Technology | BIOTIUM, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| US-8530195-B2 | Dyes and labeled molecules | BIOTIUM, INC. (US) | 2013-09-10 | — | — | US | disclosed |
| US-20130167309-A1 | METHODS OF USING DYES IN ASSOCIATION WITH NUCLEIC ACID STAINING OR DETECTION AND ASSOCIATED TECHNOLOGY | BIOTIUM, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| US-20130167309-A1 | METHODS OF USING DYES IN ASSOCIATION WITH NUCLEIC ACID STAINING OR DETECTION AND ASSOCIATED TECHNOLOGY | BIOTIUM, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| US-8232050-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2012-07-31 | — | — | US | disclosed |
| US-20100323453-A1 | Methods of Using Dyes in Association with Nucleic Acid Staining or Detection and Associated Technology | BIOTIUM, INC. (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100317016-A1 | DYES AND LABELED MOLECULES | BIOTIUM, INC. (US) | 2010-12-16 | — | — | US | disclosed |
| US-7803943-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2010-09-28 | — | — | US | disclosed |
| US-7776567-B2 | Dimeric and trimeric nucleic acid dyes, and associated systems and methods | BIOTIUM, INC. (US) | 2010-08-17 | — | — | US | disclosed |
| US-20100009454-A1 | METHODS OF USING DYES IN ASSOCIATION WITH NUCLEIC ACID STAINING OR DETECTION AND ASSOCIATED TECHNOLOGY | BIOTIUM, INC. | 2010-01-14 | — | — | US | disclosed |
| US-7601498-B2 | Methods of using dyes in association with nucleic acid staining or detection and associated technology | BIOTIUM, INC. (US) | 2009-10-13 | — | — | US | disclosed |
| US-20070044831-A1 | Electrolyte composition and dye-sensitized solar cell | NATIONAL UNIVERSITY CORPORATION KYUSHU INSTITUTE OF TECHNOLOGY (JP) | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317016-A1 | DYES AND LABELED MOLECULES | DNA2, POLL, POLRMT | BCHE 4345/4885ACHE 4290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.